Oscar Health drops as Barclays sees asymmetric downside, initiates at Underweight

Published 02/07/2025, 14:58
© Reuters.

Investing.com --Oscar Health fell 14% to $17.58 on Wednesday after Barclays (LON:BARC) began coverage with an Underweight rating, warning that the stock’s recent rally leaves it vulnerable to pullbacks as policy risks mount.

Shares surged more than 50% in June, driven largely by retail speculation following a bullish investor day, but Barclays said the optimism ignores emerging threats to Oscar’s profitability.

Analysts said it sees an asymmetric downside risk with regulatory uncertainty, potential changes to federal subsidies, and tariff-related costs hurting growth and margin targets.

The firm set a $17 price target, just below current levels.

Oscar, a digital-focused insurer operating exclusively on the Affordable Care Act exchanges, laid out plans in June to more than double margins and deliver $2.25+ per share profit by 2027.

Barclays is skeptical, projecting $1.28 instead, 25% below consensus, and modeling medical loss ratio (MLR) pressure into next year.

With new rules and subsidy expirations on the table, Oscar may have to raise premiums and lose members.

Barclays estimated over 100 basis points of MLR headwinds in most 2026 scenarios, which could shave at least 30 cents off EPS.

Proposed changes to cost-sharing reduction (CSR) funding add another layer of risk.

Though the Senate’s latest version of the reconciliation bill dropped CSR provisions, the House kept them, and Barclays said such a move could strip away no-premium bronze plans for low-income enrollees.

With 34% of Oscar’s base in bronze plans, that could drive outsized attrition and degrade the risk pool.

Oscar turned profitable only this year, and Barclays used a 14x multiple on its 2027 EPS forecast to derive its target, well below the 21x multiple assigned to prior high-growth insurers like WellCare and Molina in similar phases.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.